
Dr. Reddy’s Laboratories announces first-to-market launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose […]